FHDH-ANRS CO4 Cohort: HCV Incidence in MSM With HIV Declined Following Access to HCV DAA Therapy in France

March 8-11, 2020; Boston, Massachusetts
HCV incidence in MSM with HIV in France declined from 2014 to 2017 following unrestricted access of HCV DAA therapy for persons with HIV.
Format: Microsoft PowerPoint (.ppt)
File Size: 156 KB
Released: March 17, 2020

Acknowledgements

Provided by USF Health, in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.

Eric S. Daar, MD Darcy Wooten, MD Released: October 19, 2021

Clinical Care Options (CCO) video discussion between Drs. Renslow Sherer and Karine Lacombe on lessons learned during COVID-19 for HIV and COVID prevention

Karine Lacombe, MD, PhD Renslow Sherer, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 13, 2021 Expired: October 12, 2022

CCO slides from Drs. Renslow Sherer and Karine Lacombe on lessons learned during COVID-19 for HIV and COVID prevention

Karine Lacombe, MD, PhD Renslow Sherer, MD Released: October 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue